Newsstand Menu

Discovering how a new leukemia drug undermines cancer cells


November 30, 2015

Category: Research

Unassuming and "pathetic" protein proves lynchpin in a new cancer drug’s therapeutic action. Adaptor protein NSD3-short helps researchers explain anti-leukemia drug’s powerful effects. Feat. CSHL Associate Prof. Christopher Vakoc, MD, Ph.D.

Related story

Unassuming “Swiss Army knife”-like protein proves lynchpin in a new cancer drug’s therapeutic action